Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chad E Beyer

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Pharmacology & Therapeutics|October 3, 2006
Differentiating antidepressants of the future: efficacy and safetySharon Rosenzweig-Lipson, Chad E Beyer, Zoë A Hughes, et al.
Pharmacology, Biochemistry, and Behavior|March 24, 2009
The supra-additive hyperactivity caused by an amphetamine-chlordiazepoxide mixture exhibits an inverted-U dose response: negative implications for the use of a model in screening for mood stabilizersMichele P Kelly, Sheree F Logue, Jason M Dwyer, et al.
Psychopharmacology|March 13, 2010
Angiotensin IV elevates oxytocin levels in the rat amygdala and produces anxiolytic-like activity through subsequent oxytocin receptor activationChad E Beyer, Jason M Dwyer, Brian J Platt, et al.
Neuropeptides|July 20, 2007
Anxiolytic-like activity of the non-selective galanin receptor agonist, galnonS Johannes R Rajarao, Brian Platt, Stacey J Sukoff, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 13, 2007
Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466Lee E Schechter, Qian Lin, Deborah L Smith, et al.
Neurobiology of Disease|April 13, 2010
Depression-like phenotype following chronic CB1 receptor antagonismChad E Beyer, Jason M Dwyer, Michael J Piesla, et al.
Psychopharmacology|March 4, 2008
Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disordersSarah K Leonard, Jason M Dwyer, Stacey J Sukoff Rizzo, et al.
Bioorganic & Medicinal Chemistry|June 16, 2009
Novel 1-aminoethyl-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines are potent 5-HT(6) agonistsRonald C Bernotas, Steven Lenicek, Schuyler Antane, et al.
Journal of Medicinal Chemistry|July 21, 2006
Synthesis and biological evaluation of novel compounds within a class of 3-aminochroman derivatives with dual 5-HT1A receptor and serotonin transporter affinityNicole T Hatzenbuhler, Deborah A Evrard, Boyd L Harrison, et al.
Neuropharmacology|July 21, 2009
Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonistRobert H Ring, Lee E Schechter, Sarah K Leonard, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Pharmacology & Therapeutics|October 3, 2006
Differentiating antidepressants of the future: efficacy and safetySharon Rosenzweig-Lipson, Chad E Beyer, Zoë A Hughes, et al.
Pharmacology, Biochemistry, and Behavior|March 24, 2009
The supra-additive hyperactivity caused by an amphetamine-chlordiazepoxide mixture exhibits an inverted-U dose response: negative implications for the use of a model in screening for mood stabilizersMichele P Kelly, Sheree F Logue, Jason M Dwyer, et al.
Psychopharmacology|March 13, 2010
Angiotensin IV elevates oxytocin levels in the rat amygdala and produces anxiolytic-like activity through subsequent oxytocin receptor activationChad E Beyer, Jason M Dwyer, Brian J Platt, et al.
Neuropeptides|July 20, 2007
Anxiolytic-like activity of the non-selective galanin receptor agonist, galnonS Johannes R Rajarao, Brian Platt, Stacey J Sukoff, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 13, 2007
Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466Lee E Schechter, Qian Lin, Deborah L Smith, et al.
Neurobiology of Disease|April 13, 2010
Depression-like phenotype following chronic CB1 receptor antagonismChad E Beyer, Jason M Dwyer, Michael J Piesla, et al.
Psychopharmacology|March 4, 2008
Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disordersSarah K Leonard, Jason M Dwyer, Stacey J Sukoff Rizzo, et al.
Bioorganic & Medicinal Chemistry|June 16, 2009
Novel 1-aminoethyl-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines are potent 5-HT(6) agonistsRonald C Bernotas, Steven Lenicek, Schuyler Antane, et al.
Journal of Medicinal Chemistry|July 21, 2006
Synthesis and biological evaluation of novel compounds within a class of 3-aminochroman derivatives with dual 5-HT1A receptor and serotonin transporter affinityNicole T Hatzenbuhler, Deborah A Evrard, Boyd L Harrison, et al.
Neuropharmacology|July 21, 2009
Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonistRobert H Ring, Lee E Schechter, Sarah K Leonard, et al.
Pageof 4